Efficacy and Safety of LEO 152020 Tablets for the Treatment of Adults With Moderate to Severe Atopic Dermatitis
Clinical trial NCT05117060 · COMPLETED
Trial details
- NCT number
- NCT05117060
- Sponsor
- JW Pharmaceutical
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-13
- Primary completion
- 2023-07-20
- Enrollment
- 216
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.